Table 1.

Demographic and clinical characteristics and levels of KIAA1199 mRNA expression in NSCLC tissue

Characteristics	Number of cases (%)	KIAA1199 mRNA expression	P value
Age
≥66	20(41.7%)	0.1431 ± 0.0794	.489
<66	28(58.3%)	0.0845 ± 0.0251
Gender
Male	26(54.2%)	0.1312 ± 0.0620	.481
Female	22(45.8%)	0.0826 ± 0.2856
Histological features
Adenocarcinoma	30(62.5%)	0.1137 ± 0.0545	.947
Squamous cell carcinoma	8(16.7%)	0.1090 ± 0.0429
Others	10(20.8%)	0.0945 ± 0.0487
Tumor invasion depth
T1, T2	40(83.3%)	0.1221 ± 0.0427	.102
T3, T4	8(16.7%)	0.0432 ± 0.0202
Lymph node metastasis
Yes	16(33.3%)	0.0834 ± 0.0314	.531
No	32(66.7%)	0.1216 ± 0.0517
Distant metastasis
Yes	5(10.4%)	0.0547 ± 0.0328	.255
No	43(89.6%)	0.1152 ± 0.0399
Clinical stage
I + II	31(64.6%)	0.1402 ± 0.0546	.125
III + IV	17(35.4%)	0.0519 ± 0.0131
Degree of differential
Low	24(50.0%)	0.1510 ± 0.0691	.250
Middle	24(50.0%)	0.0668 ± 0.0184
Smoker
Yes	19(39.6%)	0.1448 ± 0.0584	.138
no	29(60.4%)	0.0541 ± 0.0114

Data are presented as means ± SEM values. Unpaired t‐test was used for comparison between two groups, and Kruskal‐Wallis test was used for comparison between three or more groups.